Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows
The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.